No evidence for allelic association of serotonin 2A receptor and transporter gene polymorphisms with depression in Alzheimer disease

Journal of Alzheimer's Disease

Volumn 10, Issue 4, 2006, Pages 371-378

  Micheli, D ^a   Bonvicini, C ^b   Rocchi, A ^a   Ceravolo, R ^a   Mancuso, Michelangelo ^a   Tognoni, G ^a   Gennarelli, M ^b   Siciliano, G ^a   Murri, L ^a  

^a UNIVERSITY OF PISA   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

Author keywords

5 HTTLPR; Depression; Polymorphisms; Serotoninergic system; T102C

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4; SEROTONIN; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN INTERACTION; RISK FACTOR; SEROTONINERGIC SYSTEM; STRATIFICATION; SYMPTOM;

EID: 33846954369     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2006-10405     Document Type: Article

References (51)

1. P.N. Tariot and L. Blazina, The psychopathology of dementia, in: Handbook of dementing illnesses, J. Morris, ed., Marcel Dekker, New York, 1994, pp. 461-475.
2. J.T. Olin, I.R. Katz, B.S. Meyers, L.S. Schneider and B.D. Lebowitz, Provisional diagnostic criteria for depression of Alzheimer disease: rationale and background, Am J Geriatr Psychiatry 10 (2002), 129-141.
3. M.A. Aletrino, O.J. Vogels, P.H. Van Domburg and H.J. Ten Donkelaar, Cell loss in the nucleus raphes dorsalis in Alzheimer's disease, Neurobiol Aging 13 (1992), 461-468.
4. A.J. Cross, T.J. Crow, I.N. Ferrier, J.A. Johnson, S.R. Bloom and J.A. Corsellis, Serotonin receptor changes in dementia of the Alzheimer type, J Neurochem 43 (1984), 1574-1581.
5. A.M. Palmer, P.T. Francis, J.S. Benton, N.R. Sims, D.M. Mann, D. Neary, J.S. Snowden and D.M. Bowen, Presynaptic serotonergic dysfunction in patients with Alzheimer's disease, J Neurochem 48 (1987), 8-15.
6. S.M. Tejani-Butt, J. Yang and A.C. Pawlyk, Altered serotonin transporter sites in Alzheimer's disease raphe and hippocampus, Neuroreport 6 (1995), 1207-1210.
7. K.L. Lanctot, N. Herrmann and P. Mazzotta, Role of serotonin in the behavioral and psychological symptoms of dementia, J Neuropsychiatry Clin Neurosci 13 (2001), 5-21.
8. A. Heils, A. Teufel, S. Petri, G. Stober, P. Riederer, D. Bengel and K.P. Lesch, Allelic variation of human serotonin transporter gene expression, J Neurochem 66 (1996), 2612-2624.
9. D.A. Collier, G. Stober, T. Li, A. Heils, M. Catalano, D. Di Bella, M.J. Arranz, R.M. Murray, H.P. Vallada, D. Bengel, C.R. Muller, G.W. Roberts, E. Smeraldi, G. Kirov, P. Sham and K.P. Lesch, A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders, Mol Psychiatry 1 (1996), 453-460.
10. T. Li, C. Holmes, P.C. Sham, H. Vallada, J. Birkett, G. Kirov, K.P. Lesch, J. Powell, S. Lovestone and D. Collier, Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimer's disease, Neuroreport 8 (1997), 683-686.
11. J.R. Oliveira, R.M. Gallindo, L.G. Maia, P.R. Brito-Marques, P.A. Otto, M.R. Passos-Bueno, M.A. Morais, Jr. and M. Zatz, The short variant of the polymorphism within the promoter region of the serotonin transporter gene is a risk factor for late onset Alzheimer's disease, Mol Psychiatry 3 (1998), 438-441.
12. M. Hu, W. Retz, M. Baader, B. Pesold, G. Adler, F.A. Henn, M. Rosler and J. Thome, Promoter polymorphism of the 5-HT transporter and Alzheimer's disease, Neurosci Lett 294 (2000), 63-65.
13. W.J. Burke, V. Dewan, S.P. Wengel, W.H. Roccaforte, G.C. Nadolny and D.G. Folks, The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia, Int J Geriatr Psychiatry 12 (1997), 519-525.
14. N. Norton and M.J. Owen, HTR2A: association and expression studies in neuropsychiatric genetics, Ann Med 37 (2005), 121-129.
15. E.K. Perry, E.F. Marshall, G. Blessed, B.E. Tomlinson and R.H. Perry, Decreased imipramine binding in the brains of patients with depressive illness, Br J Psychiatry 142 (1983), 188-192.
16. C.A. Stockmeier, Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter, J Psychiatr Res 37 (2003), 357-373.
17. C.P. Chen, J.T. Alder, D.M. Bowen, M.M. Esiri, B. McDonald, T. Hope, K.A. Jobst and P.T. Francis, Presynaptic serotonergic markers in community-acquired cases of Alzheimer's disease: correlations with depression and neuroleptic medication, J Neurochem 66 (1996), 1592-1598.
18. A.J. Thomas, M. Hendriksen, M. Piggott, I.N. Ferrier, E. Perry, P. Ince and J.T. O'brien, A study of the serotonin transporter in the prefrontal cortex in late-life depression and Alzheimer's disease with and without depression, Neuropathol Appl Neurobiol 32 (2006), 296-303.
19. C.P. Chen, S.L. Eastwood, T. Hope, B. McDonald, P.T. Francis and M.M. Esiri, Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer's disease prospectively assessed for behavioural changes, Neuropathol Appl Neurobiol 26 (2000), 347-355.
20. M. Hendricksen, A.J. Thomas, I.N. Ferrier, P. Ince and J.T. O'Brien, Neuropathological study of the dorsal raphe nuclei in late-life depression and Alzheimer's disease with and without depression, Am J Psychiatry 161 (2004), 1096-1102.
21. C.C. Meltzer, J.C. Price, C.A. Mathis, P.J. Greer, M.N. Cantwell, P.R. Houck, B.H. Mulsant, D. Ben-Eliezer, B. Lopresti, S.T. DeKosky and C.F. Reynolds, 3rd., PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders, Am J Psychiatry 15 (1999), 1871-1878.
22. A. Rocchi, D. Micheli, R. Ceravolo, M.L. Manca, G. Tognoni, G. Siciliano and L. Murri, Serotoninergic polymorphisms (5-HTTLPR and 5-HT2A): association studies with psychosis in Alzheimer disease, Genet Test 7 (2003), 309-314.
23. American Psychiatric Association, Diagnostic and Statistic Manual of Mental Disorders, (4th ed.), American Psychiatric Association, Washington, DC. 1994.
24. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price and E.M. Stadlan, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology 34 (1984), 939-944.
25. J.R. Cockrell and M.F. Folstein, Mini-Mental State Examination (MMSE), Psychopharmacol Bull 24 (1988), 689-692.
26. J.C. Morris, Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type, Int Psychogeriatr 9(Suppl 1) (1997), 173-176, discussion 177-178.
27. D. Galasko, F. Schmitt, R. Thomas, S. Jin and D. Bennett, Alzheimer's Disease Cooperative Study, Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease, J Int Neuropsychol Soc 11 (2005), 446-453.
28. J.L. Cummings, M. Mega and K. Gray, S. Rosenberg-Thompson, D.A. Carusi, J. Gornbein, The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia, Neurology 44 (1994), 2308-2314.
29. J.T. Warren, Jr., M.L. Peacock, L.C. Rodriguez and J.K. Fink, An MspI polymorphism in the human serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis, Hum Mol Genet 2 (1993), 338.
30. J.E. Hixson and D.T. Vernier, Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI, J Lipid Res 31 (1990), 545-548.
31. S. Schneider, D. Roessli and L. Excofier, Arlequin: A Software for Population Genetics Data analysis, Ver 2.000. Genetics and Biometry Lab, Dept. of Anthropology, University of Geneva, Switzerland (2000).
32. C.G. Lyketsos, M. Steinberg, J.T. Tschanz, M.C. Norton, D.C. Steffens and J. Breitner, Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging, Am J Psychiatry 157 (2000), 708-714.
33. H. Kunugi, A. Ueki, M. Otsuka, K. Isse, H. Hirasawa, N. Kato, T. Nabika, S. Kobayashi and S. Nanko, Alzheimer's disease and 5-HTTLPR polymorphism of the serotonin transporter gene: no evidence for an association, Am J Med Genet 96 (2000), 307-309.
34. P. Zill, F. Padberg, S. de Jonge, H. Hampel, K. Burger, S. Stubner, T. Boetsch, H. Jurgen Moller, M. Ackenheil and B. Bondy, Serotonin transporter (5-HTT) gene polymorphism in psychogeriatric patients, Neurosci Lett 284 (2000), 113-115.
35. S.J. Tsai, C.J. Hong, T.Y. Liu, C.Y. Cheng and H.C. Liu, Association study for a functional serotonin transporter gene polymorphism and late-onset Alzheimer's disease for Chinese patients, Neuropsychobiology 44 (2001), 27-30.
36. J. Thome, W. Retz, M. Baader, B. Pesold, M. Hu, M. Cowen, N. Durany, G. Adler, F.A. Henn and M. Rosler, Association analysis of HTR6 and HTR2A polymorphisms in sporadic Alzheimer's disease, J Neural Transm 108 (2001), 1175-1180.
37. G. Turecki, R. Briere, K. Dewar, T. Antonetti, A.D. Lesage, M. Seguin, N. Chawky, C. Vanier, M. Alda, R. Joober, C. Benkelfat and G.A. Rouleau, Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide, Am J Psychiatry 156 (1999), 1456-1458.
38. O.O. Polesskaya and B.P. Sokolov, Differential expression of the "C" and "T" alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics, J Neurosci Res 67 (2002), 812-822.
39. C. Holmes, M.J. Arranz, J.F. Powell, D.A. Collier and S. Lovestone, 5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease, Hum Mol Genet 7 (1998), 1507-1509.
40. C. Holmes, M. Arranz, D. Collier, J. Powell and S. Lovestone, Depression in Alzheimer's disease: the effect of serotonin receptor gene variation, Am J Med Genet 119 (2003), 40-43.
41. B. Nacmias, A.Tedde, P. Forleo, S. Piacentini, B.M. Guarnieri, A. Bartoli, L. Ortenzi, C. Petruzzi, A. Serio, G. Marcon and S. Sorbi, Association between 5-HT(2A) receptor polymorphism and psychotic symptoms in Alzheimer's disease, Biol Psychiatry 50 (2001), 472-475.
42. R.A. Sweet, B.G. Pollock, D.L. Sukonick, B.H. Mulsant, J. Rosen, W.E. Klunk, K.B. Kastango, S.T. DeKosky and R.E. Ferrell, The 5-HTTPR polymorphism confers liability to a combined phenotype of psychotic and aggressive behavior in Alzheimer disease, Int Psychogeriatr 13 (2001), 401-409.
43. F. Assal, M. Alarcon, E.C. Solomon, D. Masterman, D.H. Geschwind and J.L. Cummings, Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease, Arch Neurol 61 (2004), 1249-1253.
44. L.C. Lam, N.L. Tang, S.L. Ma, W. Zhang and H.F. Chiu, 5-HT2A T102C receptor polymorphism and neuropsychiatric symptoms in Alzheimer's disease, Int J Geriatr Psychiatry 19 (2004), 523-526.
45. G. Ramachandran, K. Marder, M. Tang, P.W. Schofield, M.R. Chun, D.P. Devanand, Y. Stern and R. Mayeux, A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease, Neurology 47 (1996), 256-259.
46. C.G. Lyketsos, L. Baker, A. Warren, C. Steele, J. Brandt, M. Steinberg, S. Kopunek and A. Baker, Depression, delusions, and hallucinations in Alzheimer's disease: no relationship to apolipoprotein E genotype, J Neuropsychiatry Clin Neurosci 9 (1997), 64-67.
47. M.L. Levy, J.L. Cummings, L.A. Fairbanks, D.L. Sultzer and G.W. Small, Apolipoprotein E genotype and noncognitive symptoms in Alzheimer's disease, Biol Psychiatry 45 (1999), 422-425.
48. D.G. Harwood, W.W. Barker, R.L. Ownby, P. St George-Hyslop and R. Duara, Apolipoprotein-E (APO-E) genotype and symptoms of psychosis in Alzheimer's disease, Am J Geriatr Psychiatry 7 (1999), 119-123.
49. N. Scarmeas, J. Brandt, M. Albert, D.P. Devanand, K. Marder, K. Bell, A. Ciappa, B. Tycko and Y. Stern, Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease, Neurology 58 (2002), 1182-1188.
50. R. Monastero, E. Mariani, C. Camarda, T. Ingegni, M.R. Averna, U. Senin, R. Camarda and P. Mecocci, Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease, Acta Psychiatr Scand 113 (2006), 59-63.
51. H. Forstl, A. Burns, P. Luthert, N. Cairns, P. Lantos and R. Levy, Clinical and neuropathological correlates of depression in Alzheimer's disease, Psychol Med 22 (1992), 877-884.